Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.
Also known as near-patient testing, point-of-care testing can be defined as an investigation taken at the time of the consultation with the patient. The instant availability of the results enables health care professionals to make immediate and informed decisions about patient care. In other words, point-of-care testing happens as close to the patient as possible. This testing option usually represents […]
COVID-19 diagnostic testing plays an important role in not only detecting the virus but also in controlling the pandemic. There are different types of COVID-19 tests available in 2022 which can detect SARS-CoV-2 in both symptomatic and asymptomatic people. This article features information about different types of COVID-19 tests, how they work, and what they have in common. Keep reading […]
A COVID-19 test is used to detect whether a person is infected with coronavirus (SARS-CoV-2). PCR tests have proved to be reliable and accurate tests for the rapid diagnosis of the COVID-19 infection. Let’s have a look at how COVID-19 PCR testing works and where you can get tested for COVID-19. Fluorescence PCR Fluorescence PCR (Polymerase Chain Reaction) is a […]
Since the beginning of 2020, waves of COVID-19 pandemic caused by SARS-CoV-2 and their variants have swept across the whole world. At present, it is possible for COVID-19 pandemic to become endemic due to the widespread vaccination of COVID-19 vaccines, especially the appearance of small molecule drugs against COVID-19. When everyone was relieved about COVID-19, more than 200 cases of […]
Hepatitis B (HepB) is an international public health challenge that can lead to progressive scarring in hepatocellular carcinoma and primary liver cancer, and accounts for a significant proportion of viral hepatitis. The World Health Organization estimates that 296 million people were living with chronic hepatitis B infection in 2019, with about 820,000 deaths. About 90 million people in China suffer […]